Random nucleotide mutation for nucleotide template counting and assembly

US12516367B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12516367-B2
Application numberUS-202117320634-A
CountryUS
Kind codeB2
Filing dateMay 14, 2021
Priority dateOct 10, 2014
Publication dateJan 6, 2026
Grant dateJan 6, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides a method for sequencing a nucleic acid molecule (NAM) that comprises two or more segments having substantially the same sequence, and that has a length of more than one sequencing read, comprising i) obtaining two more copies of the NAM; ii) subjecting each copy of the NAM in step i) to a mutagenesis that mutates only select nucleic acid positions in the NAMs at a rate of 10% to 90% to produce mutated copies of the NAM (mcNAM); iii) amplifying each of the mcNAMs; iv) obtaining composite sequences of the mcNAMs that are produced by assembling sequence reads of the amplified mcNAMs, such that when taken together, span as much as possible of the entire length of the NAM, thereby sequencing the NAM.

First claim

Opening claim text (preview).

What is claimed: 1 . A method for sequencing a nucleic acid molecule (NAM) that comprises two or more segments having substantially the same sequence, and that has a length of more than one sequencing read, comprising i) obtaining two or more copies of the NAM; ii) subjecting each copy of the NAM in step i) to a mutagenesis that mutates only select nucleic acid positions in the NAMs at a rate of 10% to 90% to produce mutated copies of the NAM (mcNAM); iii) amplifying each of the mcNAMs; iv) obtaining composite sequences of the mcNAMs that are produced by assembling sequence reads of the amplified mcNAMs, such that when taken together, span as much as possible of the entire length of the NAM, by a) aligning the sequence reads according to matching mutation patterns in overlaps of the sequence reads by a scoring method that assigns a weight to the overlaps in the sequence reads that reflects how unlikely it is that the overlaps agree on their mutation patterns by chance, and aligning the sequence reads by selecting overlaps that have the highest assigned weight, and b) mapping the composite sequences, thereby sequencing the NAM. 2 . The method of claim 1 , wherein each of the two or more copies of the NAM has a unique primer at its 5′ end and another unique primer at its 3′ end. 3 . The method of claim 1 , wherein the mutagenesis is by cytosine deamination. 4 . The method of claim 1 , wherein each mutable position of the NAMs comprises a cytosine (C), wherein the cytosine (C) is mutated to a uracil (U) or a thymine (T). 5 . The method of claim 1 , further comprising the step of tagging each NAM or copy thereof. 6 . The method of claim 1 , wherein the NAM is within a mixture of DNA or RNA extracted from a cell. 7 . The method of claim 1 , wherein the NAM is a DNA molecule. 8 . The method of claim 2 , wherein the unique primers of each mcNAM lack a nucleotide that is mutable by the mutagenesis. 9 . The method of claim 1 , wherein the mutagenesis is performed after binding the NAM to a bead or surface. 10 . The method of claim 3 , wherein the cytosine deamination is induced by a bisulfite or a salt thereof. 11 . The method of claim 5 , wherein the tag lacks a nucleotide that is mutable by the mutagenesis. 12 . The method of claim 6 , wherein the DNA or RNA extracted from the cell has been fragmented. 13 . The method of claim 1 , wherein the rate of mutagenizing each mutable position of the NAMs is 25% to 75%. 14 . The method of claim 1 , wherein the rate of mutagenizing each mutable position of the NAMs is 40% to 60%. 15 . The method of claim 1 , wherein the rate of mutagenizing each mutable position of the NAMs is 50%.

Assignees

Inventors

Classifications

  • Massive parallel sequencing · CPC title

  • PCR · CPC title

  • incorporating target specific and non-target specific sites · CPC title

  • Deaminase · CPC title

  • Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12516367B2 cover?
This invention provides a method for sequencing a nucleic acid molecule (NAM) that comprises two or more segments having substantially the same sequence, and that has a length of more than one sequencing read, comprising i) obtaining two more copies of the NAM; ii) subjecting each copy of the NAM in step i) to a mutagenesis that mutates only select nucleic acid positions in the NAMs at a rate o…
Who is the assignee on this patent?
Wigler Michael, Levy Dan, Cold Spring Harbor Laboratory
What technology area does this patent fall under?
Primary CPC classification C12Q1/6827. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).